Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel XR in adults with schizophrenia
NCT00852631Phase 3Terminated
- Sponsor
- AstraZeneca
- Start
- Feb 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in schizophrenia, sponsored by AstraZeneca. Started Feb 2009; status: terminated.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00852631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00852631.